Company

Kypha

Rocket Ship Rating

Rocket Ship Rating: 86 out of 100

Bringing new immune insights into view

Also known as Kypha Inc.

Medical devices & diagnostics

Status: Operatingas of 2026-09-18
Business model: B2B
Headquarters: St. Louis, MO, United States
Founded: 2010
Customers: biopharma and clinical partners, customers and collaborators
Legal name: Kypha Inc.

Open relationship map

Claim, correct or request removal

Record updated 28 September 2026

About

Kypha translates the complexities of a rapidly changing immune ecosystem into clinically actionable insights.

Funding snapshot

Total raised: $15.2MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
Latest round: Round, $5.2M2022-04-08

Funding rounds

Round, 2022: $5.2M2022-04-08, SEC form D sold, 13 investors
Round, 2018: $950K2018-06-19, SEC form D sold, 1 investor
Round, 2018: $5.5M2018-04-30, SEC form D sold, 13 investors
Round, 2015: $2.1M2015-02-20, SEC form D sold, 3 investors
Round, 2013: $398K2013-12-30, SEC form D sold, 1 investor
Round, 2013: $750K2013-03-01, SEC form D sold, 3 investors
Round, 2012: $200K2012-06-25, SEC form D sold, 1 investor
Round, 2011: $206K2011-11-22, SEC form D sold, 10 investors

Products

Hardware: Comp ACT
Hardware: RapiPlex